CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Hydromorphone hydrochloride

Last Updated: December 4, 2009
Result type: Reports
Project Number: SR0190-000
Product Line: Reimbursement Review

Generic Name: Hydromorphone hydrochloride

Brand Name: Jurnista

Manufacturer: Janssen-Ortho Inc.

Therapeutic Area: Pain, Chronic (moderate to severe)

Indications: Pain, Chronic (moderate to severe)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 19, 2010

Recommendation Type: Do not list